NOVA VISION ACQUISITION (NOVV) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:NOVV • VGG6759A1003

37.0001 USD
+24.67 (+200.08%)
Last: Sep 13, 2024, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to NOVV. NOVV was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of NOVV have multiple concerns. NOVV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year NOVV was profitable.
  • In the past year NOVV has reported a negative cash flow from operations.
NOVV Yearly Net Income VS EBIT VS OCF VS FCFNOVV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -200K -400K -600K

1.2 Ratios

Industry RankSector Rank
ROA 0.48%
ROE 0.61%
ROIC N/A
ROA(3y)-0.08%
ROA(5y)N/A
ROE(3y)-0.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NOVV Yearly ROA, ROE, ROICNOVV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -1 -2 -3

1.3 Margins

  • NOVV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NOVV Yearly Profit, Operating, Gross MarginsNOVV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • NOVV has less shares outstanding than it did 1 year ago.
  • Compared to 1 year ago, NOVV has a worse debt to assets ratio.
NOVV Yearly Shares OutstandingNOVV Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2M 4M 6M
NOVV Yearly Total Debt VS Total AssetsNOVV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

  • An Altman-Z score of 10.77 indicates that NOVV is not in any danger for bankruptcy at the moment.
  • A Debt/Equity ratio of 0.19 indicates that NOVV is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 10.77
ROIC/WACCN/A
WACCN/A
NOVV Yearly LT Debt VS Equity VS FCFNOVV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 10M 20M 30M 40M 50M

2.3 Liquidity

  • NOVV has a Current Ratio of 0.01. This is a bad value and indicates that NOVV is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NOVV has a Quick Ratio of 0.01. This is a bad value and indicates that NOVV is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.01
Quick Ratio 0.01
NOVV Yearly Current Assets VS Current LiabilitesNOVV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 500K 1M 1.5M 2M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • NOVV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.96%.
EPS 1Y (TTM)-36.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.9%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 1233.34, which means the current valuation is very expensive for NOVV.
  • The average S&P500 Price/Earnings ratio is at 27.93. NOVV is valued rather expensively when compared to this.
Industry RankSector Rank
PE 1233.34
Fwd PE N/A
NOVV Price Earnings VS Forward Price EarningsNOVV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NOVV Per share dataNOVV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • NOVV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

NOVA VISION ACQUISITION

NASDAQ:NOVV (9/13/2024, 8:00:02 PM)

37.0001

+24.67 (+200.08%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-05
Earnings (Next)N/A
Inst Owners1.08%
Inst Owner Change-6.05%
Ins Owners78.03%
Ins Owner Change0%
Market Cap73.26M
Revenue(TTM)N/A
Net Income(TTM)90.49K
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1233.34
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.92
P/tB 4.92
EV/EBITDA N/A
EPS(TTM)0.03
EY0.08%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.32
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS0
BVpS7.52
TBVpS7.52
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.48%
ROE 0.61%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.08%
ROA(5y)N/A
ROE(3y)-0.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.01
Quick Ratio 0.01
Altman-Z 10.77
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%59.9%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9%
OCF growth 3YN/A
OCF growth 5YN/A

NOVA VISION ACQUISITION / NOVV FAQ

What is the ChartMill fundamental rating of NOVA VISION ACQUISITION (NOVV) stock?

ChartMill assigns a fundamental rating of 1 / 10 to NOVV.


Can you provide the valuation status for NOVA VISION ACQUISITION?

ChartMill assigns a valuation rating of 0 / 10 to NOVA VISION ACQUISITION (NOVV). This can be considered as Overvalued.


How profitable is NOVA VISION ACQUISITION (NOVV) stock?

NOVA VISION ACQUISITION (NOVV) has a profitability rating of 0 / 10.


What is the valuation of NOVA VISION ACQUISITION based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NOVA VISION ACQUISITION (NOVV) is 1233.34 and the Price/Book (PB) ratio is 4.92.